Job Description

Company Description

Launched in 2016 as a wholly owned subsidiary of Breakthrough T1D (formerly JDRF), the T1D Fund is the first scaled venture fund established to catalyze the development of T1D cure-oriented therapies through investments. The Fund co-invests with venture capital firms and biopharma companies in support of early-stage companies pursuing disease-modifying therapies and potential cures for T1D. A core element of its mission is to rapidly advance promising therapies through development and, ultimately, regulatory approval. Led by a deeply experienced team of healthcare and investment professionals, working in partnership with an independent Investment Committee, the Fund leverages its vast research, clinical, regulatory, and medical affairs network on behalf of its portfolio companies. Funded through charitable contributions from donors and from Breakthrough T1D itself, the Fund makes investments in biotech companies and reinvests returns into new investments, thereby extending the impact of its donors’ contributions.

Scope

The T1D Fund is offering venture capital fellowship opportunities with the Investment Team in our Boston office for students currently enrolled in M.D. and/or Ph.D. programs for Fall 2026. Fellows will work closely with members of the Investment Team to conduct scientific reviews, investment due diligence, business strategy assessments, and market analyses of prospective investment opportunities. Those selected will receive hands-on training and will develop investment theses that align with our mission to accelerate treatments, preventions, and cures.

Compensation

This is a part-time internship beginning in the fall of 2026, and a stipend will be provided. Total compensation for this 15-week program is $40 per hour, with a time commitment of 10-15+ hours per week. This is an anticipated length of program with variability based on mutual alignment. The T1D Fund considers a variety of factors when determining compensation, including professional background and relevant work experience; as a result, actual compensation and length of internship may vary.

Key Responsibilities

· Evaluate new investment opportunities through scientific and commercial diligence

· Review, synthesize, and summarize primary scientific literature, company data, and external sources to shape investment strategy

· Support market landscaping and therapeutic area analyses

· Develop investment theses that align with the Fund’s mission to accelerate treatments, preventions, and cures for T1D

· Participate in investment discussions and portfolio company meetings, when appropriate

· Present findings and recommendations to members of the Investment Team

Skills and Qualifications

· Currently enrolled in an M.D., Ph.D., M.D./Ph.D., or post-doctoral program in a life sciences discipline with 1-2 years until graduation

· Available to work in a hybrid capacity from the Boston office during Fall 2026

· Strong scientific foundation in immunology, or related fields

· Demonstrated interest in venture capital, biotechnology, or life science investing

· Excellent analytical and critical-thinking skills

· Strong written and verbal communication skills

· Ability to synthesize complex scientific information into concise recommendations

· Proficiency with Microsoft PowerPoint and Excel required

· Ability to work independently and collaboratively in a fast-paced environment

Applications are reviewed on a rolling basis. Thank you for your interest and we look forward to getting to know you.

Equal Opportunity

Requests for medical, religious, and other exemptions will be considered on an individual basis. The T1D Fund, a whole owned subsidiary of Breakthrough T1D, will comply with all federal, state, and local laws.

The T1D Fund & Breakthrough T1D supports a diverse and inclusive workforce. The T1D Fund & Breakthrough T1D is an Equal Opportunity Employer. All your information will be kept confidential according to EEO guidelines.